HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

Is V-in-V the Treatment of Choice in Cases of Failed Biological Prosthesis?

Courtesy of Dr. Carlos Fava. The treatment of choice for failed biological aortic prostheses has always been redo surgery...

Does Surgeon (Instead of Operator) Experience Affect TAVR?

There is a correlation between the volume of conventional surgical aortic valve replacement procedures and better outcomes...

TAVR Long-Term Durability: from the Cath Lab to Real Life

Nominally deployed transcatheter heart valves SAPIEN 3 has shown excellent durability in accelerated testing to an equivalent...

Cerebrovascular Events After TAVR May Be Especially Serious

Stroke events do not seem to be related to valve thrombosis or structural degeneration, but to a...

SURTAVI Follow-Up Completed with Good News

The assessment of all severe aortic stenosis patients at intermediate risk of the SURTAVI was finally completed,...

TAVR Reaches Low-Risk Patients with Bicuspid Valves

Transcatheter aortic valve replacement (TAVR) seems to be safe in low-risk patients with bicuspid aortic valve stenosis....

Procedural Rescheduling Criteria in the Pandemic Era

Patients with structural heart disease are at higher risk in the face of the new coronavirus infection...

Promising Outcomes of Transcatheter Mitral Valve Replacement in Complex Patients

Courtesy of Dr. Carlos Fava. The risk of repeat surgical mitral valve repair involves 6% to15% mortality at...